CSI Market
Sign In | Register

Telomir Pharmaceuticals Inc (TELO) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access TELO Annual Balance Sheets →
Balance sheet patterns shown here provide context for understanding Telomir Pharmaceuticals Inc's financial stability and long-term positioning.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent5.17
Cash & Short-term Investments5.00
Prepaid Expense, Current AS0.20
Total Current Assets5.37
Other Assets, Noncurrent0.00
Total Assets5.37
Liabilities
Accounts Payable and Accrued Liabilities, Current LI0.20
Loans Payable, Current NO0.14
Other Liabilities, Current0.00
Total Current Liabilities0.33
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Due To Officer-
Accrued Compensation-
Total Liabilities0.33
Stockholders' Equity
Additional Paid In Capital Common Stock48.76
Retained Earnings / Accumulated Deficit-43.72
Common Stockholder's Equity5.03
Total Stockholder's Equity5.03
Liabilities & Stockholder's Equity5.37
4 historic quarters locked

Sign in to unlock the full Telomir Pharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Telomir Pharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 13, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-037854

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License